1. Home
  2. GROW vs PMN Comparison

GROW vs PMN Comparison

Compare GROW & PMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GROW
  • PMN
  • Stock Information
  • Founded
  • GROW 1968
  • PMN 2004
  • Country
  • GROW United States
  • PMN Canada
  • Employees
  • GROW N/A
  • PMN N/A
  • Industry
  • GROW Investment Managers
  • PMN Pharmaceuticals and Biotechnology
  • Sector
  • GROW Finance
  • PMN Health Care
  • Exchange
  • GROW Nasdaq
  • PMN Nasdaq
  • Market Cap
  • GROW 32.9M
  • PMN 29.8M
  • IPO Year
  • GROW N/A
  • PMN N/A
  • Fundamental
  • Price
  • GROW $2.45
  • PMN $0.91
  • Analyst Decision
  • GROW
  • PMN
  • Analyst Count
  • GROW 0
  • PMN 0
  • Target Price
  • GROW N/A
  • PMN N/A
  • AVG Volume (30 Days)
  • GROW 30.6K
  • PMN 42.8K
  • Earning Date
  • GROW 02-12-2025
  • PMN 03-31-2025
  • Dividend Yield
  • GROW 3.63%
  • PMN N/A
  • EPS Growth
  • GROW N/A
  • PMN N/A
  • EPS
  • GROW 0.12
  • PMN N/A
  • Revenue
  • GROW $10,008,000.00
  • PMN N/A
  • Revenue This Year
  • GROW N/A
  • PMN N/A
  • Revenue Next Year
  • GROW N/A
  • PMN N/A
  • P/E Ratio
  • GROW $20.43
  • PMN N/A
  • Revenue Growth
  • GROW N/A
  • PMN N/A
  • 52 Week Low
  • GROW $2.38
  • PMN $0.87
  • 52 Week High
  • GROW $2.95
  • PMN $2.61
  • Technical
  • Relative Strength Index (RSI)
  • GROW 50.62
  • PMN 46.40
  • Support Level
  • GROW $2.43
  • PMN $0.90
  • Resistance Level
  • GROW $2.50
  • PMN $1.00
  • Average True Range (ATR)
  • GROW 0.05
  • PMN 0.06
  • MACD
  • GROW 0.00
  • PMN 0.00
  • Stochastic Oscillator
  • GROW 37.50
  • PMN 23.00

About GROW U.S. Global Investors Inc.

US Global Investors Inc is a registered investment advisory firm. The company manages the following business segments: Investment management services; through which the company offers, to U.S. Global Investors Funds (USGIF or the Funds) and exchange-traded fund (ETF) clients, a range of investment management products and services to meet the needs of individual and institutional investors; and Corporate Investments, through which the company invests for its own account in an effort to add growth and value to its cash position. It derives all its revenue from Investment management services.

About PMN ProMIS Neurosciences Inc. (ON)

ProMIS Neurosciences Inc is a clinical-stage biotechnology company focused on generating and developing antibody therapeutics selectively targeting toxic misfolded proteins in neurodegenerative diseases such as Alzheimer's disease (AD), amyotrophic lateral sclerosis (ALS) and multiple system atrophy (MSA). Its proprietary target discovery engine is based on the use of two complementary techniques. The company applies its thermodynamic, computational discovery platform-ProMIS and Collective Coordinates to predict novel targets known as Disease Specific Epitopes on the molecular surface of misfolded proteins.

Share on Social Networks: